Inhibition of histone acetyltransferase by glycosaminoglycans
about
Proteoglycan form and function: A comprehensive nomenclature of proteoglycansSyndecan-1 in Cancer: Implications for Cell Signaling, Differentiation, and PrognosticationEpigenetics of neural repair following spinal cord injuryA computational approach for deciphering the organization of glycosaminoglycansMechanisms of heparanase inhibitors in cancer therapy.Heparanase regulates levels of syndecan-1 in the nucleus.The Identification of a SIRT6 Activator from Brown Algae Fucus distichusSmall molecule inhibitors of histone acetyltransferases as epigenetic tools and drug candidates.Prognostic value of heparanase expression and cellular localization in oral cancer.Shed syndecan-1 translocates to the nucleus of cells delivering growth factors and inhibiting histone acetylation: a novel mechanism of tumor-host cross-talk.Heparanase-mediated loss of nuclear syndecan-1 enhances histone acetyltransferase (HAT) activity to promote expression of genes that drive an aggressive tumor phenotypeHeparan sulfate in the nucleus and its control of cellular functions.Heparan sulfate and heparanase play key roles in mouse β cell survival and autoimmune diabetes.Disubstituted naphthyl β-D-xylopyranosides: Synthesis, GAG priming, and histone acetyltransferase (HAT) inhibition.Significance of heparanase in cancer and inflammation.Proteoglycans in cancer biology, tumour microenvironment and angiogenesis.Creating a pro-survival and anti-inflammatory phenotype by modulation of acetylation in models of hemorrhagic and septic shock.Heparan sulfate: a ubiquitous glycosaminoglycan with multiple roles in immunityHeparanase and autoimmune diabetes.Cell-autonomous heparanase modulates self-renewal and migration in bone marrow-derived mesenchymal stem cellsGlycosaminoglycans: key players in cancer cell biology and treatment.The heparanase/syndecan-1 axis in cancer: mechanisms and therapies.Heparan sulfate-protein binding specificity.2-O, 3-O Desulfated Heparin Blocks High Mobility Group Box 1 Release by Inhibition of p300 Acetyltransferase Activity.Heparanase: roles in cell survival, extracellular matrix remodelling and the development of kidney disease.Molecular targets and signaling pathways regulated by nuclear translocation of syndecan-1.
P2860
Q21710680-A096F8BF-D781-407D-B65E-77AF0833E76FQ26784262-C6E7B02B-81FD-4FDA-A734-743DCEDB0716Q26995255-3F6927BB-9DD5-4213-8918-F06326352D76Q28473002-6310F02F-E617-47D0-94A3-F2D37CC40508Q30244089-06089DA1-9611-48B5-B37C-5DE2F7B16CB1Q33420350-81F55C33-59B1-459A-828E-0667BAE7FB6EQ33833447-B4DD8326-2B27-43A7-9840-9A917374A564Q34123380-35B5318F-A261-4C4C-BD35-68FD1C4AE75EQ34440769-18849825-2866-45D9-980F-958885B9A665Q34958906-3E0900B1-3E4B-4E05-9DD1-4F138AD6DAD0Q35182839-ADBF7127-2AE3-4501-B226-A04AE6C243BEQ35190552-6462F86D-7EFB-42F2-8F0F-DE83B89860C1Q35640553-DB6B68EA-D5F1-438A-BF3F-E97FF07B76FEQ35973008-3A91F414-3AD3-404C-8CB8-2EC548E4F321Q36101233-2E8E8CD1-99AD-4F86-A35F-F2639A17A4DCQ36787608-86F6A8DD-2DD4-4C97-AB0B-B5BA2743B323Q36972324-82A19DA0-1FD6-4B39-AC56-DC1EDAD5A40DQ37400143-3F0251D0-542F-49F1-BE92-0BB5B3B61D83Q37413886-4723B85F-B759-4CAB-A30D-160543A93A7EQ37716635-05397176-A9BA-43A8-8F22-3BF555713A64Q37983930-F3CB38D3-4F20-476C-8DF0-7E14C14986B9Q38078480-9C9F4626-EE83-4B25-9045-45F51F77A473Q38134808-4B64F5C6-30A9-45D8-BC1B-4A1389C1BAEDQ38748673-99508DB9-3F13-4B36-ACA3-8A7D8CE1EC1FQ39120713-F9F0DE8D-3225-440C-9805-2AFA83780B3EQ47318797-539F7E80-D04D-4473-9380-B57596054769
P2860
Inhibition of histone acetyltransferase by glycosaminoglycans
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inhibition of histone acetyltransferase by glycosaminoglycans
@en
Inhibition of histone acetyltransferase by glycosaminoglycans.
@nl
type
label
Inhibition of histone acetyltransferase by glycosaminoglycans
@en
Inhibition of histone acetyltransferase by glycosaminoglycans.
@nl
prefLabel
Inhibition of histone acetyltransferase by glycosaminoglycans
@en
Inhibition of histone acetyltransferase by glycosaminoglycans.
@nl
P2093
P2860
P356
P1476
Inhibition of histone acetyltransferase by glycosaminoglycans
@en
P2093
Celeste B Rich
Edward Hsia
Jo Ann Buczek-Thomas
Judith A Foster
Matthew A Nugent
P2860
P304
P356
10.1002/JCB.21803
P577
2008-09-01T00:00:00Z